ERAS (Enhanced Recovery After Surgery) and Multimodal Analgesia in Laparoscopic Cholecystectomy

Not yet recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

April 20, 2025

Primary Completion Date

July 20, 2025

Study Completion Date

August 20, 2025

Conditions
Laparoscopic Cholecystectomy
Interventions
OTHER

Control group - 1

Patient data will be collected retrospectively from the records.

DRUG

Observation group -2

In the literature, multimodal analgesia strategies-as recommended by ERAS guidelines and supported by recent studies-are implemented. In the intraoperative period, patients receive paracetamol, NSAIDs, and local surgical wound infiltration analgesia. In the postoperative period, oral paracetamol and NSAIDs are routinely continued, with opioids administered as needed.

Trial Locations (1)

Unknown

Cukurova University, Sarıçam

All Listed Sponsors
collaborator

Toros University

OTHER

lead

Cukurova University

OTHER

NCT06885086 - ERAS (Enhanced Recovery After Surgery) and Multimodal Analgesia in Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter